mFOLFIRINOX regimen

modified FOLFIRINOX

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for mFOLFIRINOX regimen, covering 2025-01-07 to 2025-01-07. Get the full timeline:

Most recent: Clinical Trial Update: mFOLFIRINOX Plus Anlotinib and Sintilimab for Advanced Pancreatic Cancer [Phase 1, Phase 2]